Oncology

Latest News

AJMC Q&A with Robert Kratzke | Background image credit: ipopba - stock.adobe.com
Making Reflexive Testing the Standard of Care in Lung Cancer: Robert Kratzke, MD

July 22nd 2025

There is a great need to streamline the process from the tissue sample to the diagnostic lab, whether it's genomic or immunohistochemistry, Robert Kratzke, MD, says.

Cancer diagnosis financial strain | Image Credit: Maggie-sort.chatgpt.com
Cancer Diagnoses Bring Major Financial Burden for Privately Insured Adults

July 21st 2025

COVID-19 vaccine for patients with cancer. | Image Credit: Framestock - stock.adobe.com
COVID-19 Boosters Crucial for Patients With Cancer Despite Low Uptake

July 17th 2025

AJMC Q&A with Robert Kratzke | Background image credit: ipopba - stock.adobe.com
Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD

July 15th 2025

The investigators found that patients with SCLC and cachexia were more likely to have problems with treatment. | Image credit: appledesign - stock.adobe.com
Cachexia Worsens Prognosis in Older Patients With Advanced SCLC

July 9th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
July 22nd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 22nd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Dr James Hamrick Highlights How Technology Eases Burdens on Research Staff
May 25th 2018

Dr James Hamrick Highlights How Technology Eases Burdens on Research Staff

Technology can be used to make it easier for patients and practices to participate in clinical trials, while also easing some of the burden on research staff, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.
Ian Manners Outlines Pharma's Participation in Providing Financial Assistance for Patients
May 23rd 2018

Ian Manners Outlines Pharma's Participation in Providing Financial Assistance for Patients

Only a small percent of patients eligible for assistance programs actually enroll, and Vivor is working with pharmaceutical companies to make the process of using patient assistance programs smoother, said Ian Manners, founder and CEO of Vivor.
Site Logo
May 23rd 2018

Cancer Mortality in the United States Continues to Decline

Jaime Rosenberg
While cancer incidence rates have decreased among men, they've remained stable among women and have increased among children; however, there has been an overall decline in mortality rates among men, women, and children.
Site Logo
May 22nd 2018

All-Cause Healthcare Payments Substantial for Younger Adults With Depression, and Other Poster Findings at ISPOR

Laura Joszt, MA
Posters presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Maryland, highlighted healthcare costs for patients with treatment-resistant depression, off-label drug use in children with depressive disorder, and incidence of depression in patients diagnosed with late-stage cancer.
Rucaparib May Have Potential Clinical Benefit for Advanced Pancreatic Cancer
May 22nd 2018

Rucaparib May Have Potential Clinical Benefit for Advanced Pancreatic Cancer

Jaime Rosenberg
Rucaparib, the PARP inhibitor approved for the treatment of ovarian cancer, may have potential clinical benefit for patients with advanced pancreatic cancer and a BRCA1/2 mutation.
Dr Mark Fleury on 21st Century Cures and Cancer Care
May 21st 2018

Dr Mark Fleury on 21st Century Cures and Cancer Care

The 21st Century Cures Act, in many ways, helps drugs in other disease areas going through review with FDA get to the same standard of the oncology area, said Mark Fleury, PhD, MS, principal of Policy Development and Emerging Science at the American Cancer Society Cancer Action Network (ACS CAN).
Michele McCourt Explains CancerCare's Role in Supporting Patients
May 20th 2018

Michele McCourt Explains CancerCare's Role in Supporting Patients

Beyond helping with co-payment assistance for patients with cancer, CancerCare helps with practical and emotional supports for patients, explained Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation.
Podcast: This Week in Managed Care—A Plan to Drive Down Drug Prices and Other Health News
May 19th 2018

Podcast: This Week in Managed Care—A Plan to Drive Down Drug Prices and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: May 18, 2018
May 18th 2018

This Week in Managed Care: May 18, 2018

This week, the top managed care stories included President Donald Trump's plan to drive down drug prices; the FDA approved the first biosimilar of the year; a study found rapid uptake of PD-1 agents after FDA approval.
Immune Checkpoint Inhibitors Demonstrate Better Response in Men Than Women
May 17th 2018

Immune Checkpoint Inhibitors Demonstrate Better Response in Men Than Women

Jaime Rosenberg
While immune checkpoint inhibitors significantly improve overall survival in both sexes, the magnitude of benefit is dependent on sex, according to new study findings.
Dr Mark Soberman Discusses Integrated Care Teams in Oncology
May 16th 2018

Dr Mark Soberman Discusses Integrated Care Teams in Oncology

Integrated care teams will create more value for the patient, but there are multiple challenges in the creation of these teams, said Mark Soberman, MD, MBA, FACS, former president of the Association of Community Cancer Centers.
Thomas Asfeldt Highlights 3 Key Challenges to Creating Integrated Cancer Care Teams
May 15th 2018

Thomas Asfeldt Highlights 3 Key Challenges to Creating Integrated Cancer Care Teams

Creating integrated cancer care teams is part of a paradigm shift that requires thinking of care delivery in a different way, explained Thomas Asfeldt, MBA, RN, director of Outpatient Cancer Services at Sanford Cancer Center.
Study Finds Rapid Uptake of Anti–PD-1 Agents Following FDA Approval
May 14th 2018

Study Finds Rapid Uptake of Anti–PD-1 Agents Following FDA Approval

Jaime Rosenberg
In the 4 months following their approvals, pembrolizumab and nivolumab reached more than 60% of eligible patients with melanoma, non-small cell lung cancer, and renal cell carcinoma.
Dr Oliver Dorigo Discusses an Interdisciplinary Approach to Care in Gynecologic Oncology
May 14th 2018

Dr Oliver Dorigo Discusses an Interdisciplinary Approach to Care in Gynecologic Oncology

An interdisciplinary approach to patient care is very important because the treatment of gynecologic cancers can be very complex, explained Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.
Dr Robert Navarro Foresees Unintended Consequences From Shift to Value-Based Care
May 12th 2018

Dr Robert Navarro Foresees Unintended Consequences From Shift to Value-Based Care

We have to decide if we’re prepared to not cover low-value treatments as we shift to value-based care, said Robert Navarro, PharmD, clinical professor, College of Pharmacy, University of Florida.
USPSTF Recommends Patient Choice for Prostate Cancer Screening
May 11th 2018

USPSTF Recommends Patient Choice for Prostate Cancer Screening

Jaime Rosenberg
The US Preventive Services Task Force (USPSTF) recommends that men aged 55 to 69 make their own decision on whether or not to be screened periodically for prostate cancer after they have had a conversation with their physician on potential benefits and harms.
Ted Okon Highlights the 3 Top Legislative Priorities for COA
May 9th 2018

Ted Okon Highlights the 3 Top Legislative Priorities for COA

There are 3 legislative priorities for the Community Oncology Alliance (COA) that keep the focus on the patient and ensure better care, explained Ted Okon, executive director of COA, at the 2018 Community Oncology Conference.
CAR T Therapy Case Study Shows Early Success in Treatment of Acute Myeloid Leukemia
May 9th 2018

CAR T Therapy Case Study Shows Early Success in Treatment of Acute Myeloid Leukemia

Samantha DiGrande
A new case study found that an acute myeloid leukemia patient has remained cancer free for 9 months following treatment with the chimeric antigen receptor (CAR) T-cell treatment, CYAD-01, and a bone marrow transplant.
Dr Derek Raghavan: Evidence-Based Guidelines Will Improve Cancer Outcomes, Reduce Costs
May 9th 2018

Dr Derek Raghavan: Evidence-Based Guidelines Will Improve Cancer Outcomes, Reduce Costs

The purpose of evidence-based guidelines is to reduce the level of variation, improve outcomes, and reduce costs, said Derek Raghavan, MD, PhD, FACP, FRACP, president, Carolinas HealthCare System's Levine Cancer Institute.
Dr Aimee Tharaldson on Recently Approved Specialty Drugs, Upcoming Approvals to Watch
May 5th 2018

Dr Aimee Tharaldson on Recently Approved Specialty Drugs, Upcoming Approvals to Watch

Jaime Rosenberg
Aimee Tharaldson, PharmD, a senior clinical consultant in Emerging Therapeutics for Express Scripts, discusses specialty drugs that have recently been approved, and which we will likely see approved in the remainder of the year.
Dr Sean C. Dowdy on Delays Between Discovering Improved Treatment, Practice and the Application of It
May 5th 2018

Dr Sean C. Dowdy on Delays Between Discovering Improved Treatment, Practice and the Application of It

Sean C. Dowdy, MD, chair, division of gynecologic surgery, department of obstetrics and gynecology, Mayo Clinic, discusses identified factors that cause prolonged delays between discovering an improved treatment or practice and the application of it.
Podcast: This Week in Managed Care—Insurance Coverage Gains Reverse and Other Health News
May 5th 2018

Podcast: This Week in Managed Care—Insurance Coverage Gains Reverse and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: May 4, 2018
May 4th 2018

This Week in Managed Care: May 4, 2018

This week, the top managed care stories included a report that insurance coverage gains are reversing; a deal to lower the cost of Praluent for Express Scripts members; findings that synthetic opioids are playing a bigger role in overdose deaths.
Dr Donna Hansel Discusses Challenges When Treating Advanced Bladder Cancer
May 4th 2018

Dr Donna Hansel Discusses Challenges When Treating Advanced Bladder Cancer

Funding is the biggest challenge scientists and clinical investigators face when trying to find successful therapies to treat advanced bladder cancer, explained Donna Hansel, MD, PhD, of University of California, San Diego, School of Medicine.
AJMC® in the Press, May 4, 2018
May 4th 2018

AJMC® in the Press, May 4, 2018

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Dr Charles Saunders Outlines the Increasing Importance of Technology in Practices
May 3rd 2018

Dr Charles Saunders Outlines the Increasing Importance of Technology in Practices

Practices increasingly need to use technology to deliver care in an increasingly value-based world, said Charles Saunders, MD, CEO of Integra Connect.
FDA Approves CAR T-Cell Treatment Kymriah for Adult B-Cell Lymphoma
May 2nd 2018

FDA Approves CAR T-Cell Treatment Kymriah for Adult B-Cell Lymphoma

Jaime Rosenberg
Tisagenlecleucel, sold as Kymriah, has gained its second indication following the FDA's approval of the chimeric antigen receptor T-cell therapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, the most common form of non-Hodgkin lymphoma.
What We're Reading: Kymriah's Second Indication; NIH All of Us Database; Kansas' Medicaid Lifetime Limits
May 2nd 2018

What We're Reading: Kymriah's Second Indication; NIH All of Us Database; Kansas' Medicaid Lifetime Limits

AJMC Staff
The chimeric antigen receptor T-cell therapy tisagenlecleucel has been approved for a second type of blood cancer; the National Institutes of Health has started recruiting individuals for a database that will include data on more than 1 million people; Kansas’ request to impose a 3-year lifetime limit on Medicaid benefits is testing just how open the Trump administration is to allowing states flexibility.
FDA, FTC Warn 13 Firms for Selling Vaping Juice With Kid-Friendly Appeal
May 1st 2018

FDA, FTC Warn 13 Firms for Selling Vaping Juice With Kid-Friendly Appeal

Allison Inserro
The FDA and the FTC issued 13 warning letters Tuesday to manufacturers, distributors, and retailers for selling e-liquids used in e-cigarettes, or vaping devices, with labeling or advertising that bears stark resemblances to kid-friendly food products, such as juice boxes, candy, or cookies.
Dr Mark Soberman on the Importance of Communication Among Integrated Care Teams
May 1st 2018

Dr Mark Soberman on the Importance of Communication Among Integrated Care Teams

Communication is critical in providing integrated, comprehensive care, said Mark Soberman, MD, MBA, FACS, former president of the Association of Community Cancer Centers (ACCC).
<1
...
495051525354555657
...
186>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo